Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease
- Substances:Napazimone
Germany- Participants:18–64 years · 65+ years
- Substances:Napazimone
- Sponsor:Pharming Technologies B.V.
Rare diseases
Investigational molecules
Locations
Back to Germany577 clinical trials in Bernburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
GermanyEarly switch to oral amoxicillin (drug combination) for adults with vertebral osteomyelitis: a randomised non‑inferiority trial
GermanyStudy on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
GermanyStudy on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma
GermanyStudy of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy
GermanyStudy of Tersolisib and a drug combination for adults with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
GermanyFirst-line treatment of metastatic non‑small cell lung cancer with high PD‑L1 expression: ivonescimab versus pembrolizumab
GermanyA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
GermanyLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
GermanyA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
GermanyA Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer
GermanyStudy on the Safety and Effects of Lutetium Lu-177 and ABY-271 in Patients with HER2-Positive Metastatic Breast Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research exploring natural therapeutic solutions for women experiencing primary dysmenorrhea, focusing on the potential benefits of Vitex agnus-castus extract in managing menstrual pain.
Clinical evaluation over multiple menstrual cycles to assess treatment effectiveness.
Groundbreaking studies on Live Biotherapeutic Products for treating acute vaginal infections, investigating novel approaches to women's health through targeted therapeutic interventions.
Evaluating innovative treatment options for common gynecological conditions.
Advanced research into managing treatment-induced symptoms in breast cancer patients, specifically addressing vasomotor symptoms caused by endocrine therapy.
Testing new therapeutic approaches to improve quality of life during cancer treatment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.